SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-255050
Filing Date
2024-11-12
Accepted
2024-11-12 06:14:03
Documents
14
Period of Report
2024-11-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d899938d8k.htm   iXBRL 8-K 26395
  Complete submission text file 0001193125-24-255050.txt   183591

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20241108.xsd EX-101.SCH 3878
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20241108_def.xml EX-101.DEF 13674
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20241108_lab.xml EX-101.LAB 22623
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20241108_pre.xml EX-101.PRE 14642
17 EXTRACTED XBRL INSTANCE DOCUMENT d899938d8k_htm.xml XML 5486
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 241442937
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)